Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoom
ZM
|
+$806M |
| 2 |
AbbVie
ABBV
|
+$481M |
| 3 |
T-Mobile US
TMUS
|
+$464M |
| 4 |
Kroger
KR
|
+$430M |
| 5 |
Baidu
BIDU
|
+$423M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.35B |
| 2 |
AGN
Allergan plc
AGN
|
+$1.26B |
| 3 |
S
Sprint Corporation
S
|
+$675M |
| 4 |
Amgen
AMGN
|
+$488M |
| 5 |
Humana
HUM
|
+$450M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.76% |
| 2 | Technology | 16.41% |
| 3 | Consumer Staples | 10.58% |
| 4 | Consumer Discretionary | 10.13% |
| 5 | Communication Services | 9.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NIU
1326
Niu Technologies
NIU
$158M
| $8.42M | 0.01% |
526,323
+96,870
| +23% | +$975K |
|
1327
Hain Celestial
HAIN
$52.5M
| $8.41M | 0.01% |
266,922
+168,900
| +172% | +$4.88M |
|
1328
AngioDynamics
ANGO
$646M
| $8.41M | 0.01% |
826,681
-73,633
| -8% | -$759K |
|
|
PPBI
1329
DELISTED
Pacific Premier Bancorp
PPBI
| $8.38M | 0.01% |
386,405
+371,505
| +2,493% | +$7.45M |
|
1330
iShares MSCI Brazil ETF
EWZ
$8.51B
| $8.36M | 0.01% |
290,700
+247,400
| +571% | +$6.48M |
|
1331
Clearfield
CLFD
$393M
| $8.35M | 0.01% |
597,973
+1,300
| +0.2% | +$16.8K |
|
1332
Red Rock Resorts
RRR
$3.78B
| $8.34M | 0.01% |
+764,700
| New | +$8.64M |
|
1333
iShares MSCI Taiwan ETF
EWT
$11.5B
| $8.33M | 0.01% |
+207,200
| New | +$7.71M |
|
1334
Comtech Telecommunications
CMTL
$53M
| $8.27M | 0.01% |
489,900
-339,350
| -41% | -$5.74M |
|
|
BRFS
1335
DELISTED
BRF SA
BRFS
| $8.26M | 0.01% |
2,080,160
-2,801,839
| -57% | -$10.8M |
|
1336
MACOM Technology Solutions
MTSI
$23.9B
| $8.26M | 0.01% |
+240,315
| New | +$7.02M |
|
1337
BioXcel Therapeutics
BTAI
$37.7M
| $8.25M | 0.01% |
9,725
+5,194
| +115% | +$3.39M |
|
1338
NBT Bancorp
NBTB
$2.79B
| $8.22M | 0.01% |
267,107
+20,107
| +8% | +$626K |
|
1339
CF Industries
CF
$17.9B
| $8.21M | 0.01% |
291,815
-1,099,961
| -79% | -$31.3M |
|
1340
Alpha and Omega Semiconductor
AOSL
$908M
| $8.2M | 0.01% |
754,000
-80,800
| -10% | -$828K |
|
1341
iShares 1-3 Year Treasury Bond ETF
SHY
$25.5B
| $8.2M | 0.01% |
94,700
+83,646
| +757% | +$7.24M |
|
|
ARGO
1342
DELISTED
Argo Group International Holdings, Ltd.
ARGO
| $8.2M | 0.01% |
235,465
+96,300
| +69% | +$3.21M |
|
1343
Madrigal Pharmaceuticals
MDGL
$11.8B
| $8.2M | 0.01% |
72,382
+45,900
| +173% | +$4.51M |
|
1344
ProPetro Holding
PUMP
$1.47B
| $8.18M | 0.01% |
+1,590,500
| New | +$7.33M |
|
1345
Kilroy Realty
KRC
$4.26B
| $8.16M | 0.01% |
139,105
-3,595
| -3% | -$218K |
|
1346
Regional Management Corp
RM
$308M
| $8.16M | 0.01% |
460,737
-76,737
| -14% | -$1.2M |
|
|
BRT
1347
BRT Apartments
BRT
$271M
| $8.15M | 0.01% |
753,023
-20,200
| -3% | -$206K |
|
1348
Ascendis Pharma A/S
ASND
$16.2B
| $8.15M | 0.01% |
55,082
+4,004
| +8% | +$550K |
|
1349
NMI Holdings
NMIH
$3.43B
| $8.14M | 0.01% |
506,259
-805,300
| -61% | -$11.5M |
|
1350
Millicom
TIGO
$15.7B
| $8.14M | 0.01% |
311,126
+244,879
| +370% | +$6.36M |
|
Similar funds
Jim Simons's Q2 2020 Portfolio in Review
As of Q2 2020, Jim Simons held 3,987 positions worth $116B, up 13% from $103B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Jim Simons withdrew a net $8.24B in Q2 2020, closing 596 positions and reducing 1,366 holdings. Its most notable exit was Allergan plc, an estimated $1.26B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 26% a quarter earlier, followed by Technology and Consumer Staples.
Against the trend, Jim Simons opened a new position in Uber worth $187M.
- Jim Simons's largest Q2 2020 buy was Uber: 6,030,316 shares worth $187M.
- Jim Simons added most to Zoom in Q2 2020, an estimated $806M increase.
- Jim Simons's biggest Q2 2020 reduction was Bristol-Myers Squibb, cutting an estimated $1.35B.
- Jim Simons fully exited Allergan plc in Q2 2020, selling an estimated $1.26B.
- Jim Simons's ten largest holdings make up 14% of its $116B portfolio in Q2 2020.
- Jim Simons opened 584 new positions and closed 596 in Q2 2020.
- Jim Simons's portfolio value rose 13% quarter-over-quarter to $116B.
Based on Renaissance Technologies's 13F filing for Q2 2020, filed 13 Aug 2020.